SCHEMBL259303

SCHEMBL259303

Cc1cccc(NC(=O)c2cccnc2N)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 2/20 0.69
VCP P55072 4/20 0.61
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
ALDH1A1 P00352 3/20 0.59
L3MBTL1 Q9Y468 1/20 0.56
PDGFRB P09619 1/20 0.55
KDR P35968 1/20 0.55
RXFP1 Q9HBX9 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 1/20 0.52
AURKA O14965 1/20 0.52
AURKB Q96GD4 1/20 0.52
PLK4 O00444 1/20 0.52
MAP4K4 O95819 1/20 0.52
EGFR P00533 1/20 0.52
CDK1 P06493 1/20 0.52
FES P07332 1/20 0.52
PIM1 P11309 1/20 0.52
MARK3 P27448 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23367919 0.83 ALDH1A1 (0.64) MEN1KMT2AALDH1A1L3MBTL1RXFP1
SCHEMBL25565213 0.82 PRKCI (1.00) PRKCIVCPMEN1KMT2AALDH1A1
SCHEMBL29965281 0.82 PRKCI (1.00) PRKCIVCPMEN1KMT2AALDH1A1
SCHEMBL259352 0.81 MEN1 (0.72) MEN1KMT2AALDH1A1L3MBTL1RXFP1
SCHEMBL31424193 0.81 MEN1 (0.72) MEN1KMT2AALDH1A1L3MBTL1RXFP1
SCHEMBL3113627 0.80 PTGS1 (0.68) PRKCIMEN1KMT2AALDH1A1L3MBTL1
SCHEMBL922567 0.77 HPGD (0.68) KMT2AALDH1A1AURKAKDM4E
SCHEMBL7181742 0.77 MEN1 (0.71) MEN1KMT2AALDH1A1L3MBTL1RXFP1
SCHEMBL22573428 0.77 MEN1 (0.50) MEN1KMT2AALDH1A1L3MBTL1PDGFRB
SCHEMBL29723905 0.77 KDR (0.72) MEN1KMT2AALDH1A1KDRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067586-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2011-11-29 US disclosed
US-8067586-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2011-11-29 US disclosed
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES HAYAKAWA MASAHIKO 2010-06-03 US disclosed
US-20070037805-A1 Fused heteroaryl derivatives HAYAKAWA MASAHIKO 2007-02-15 US disclosed
US-20070037805-A1 Fused heteroaryl derivatives HAYAKAWA MASAHIKO 2007-02-15 US disclosed
US-7173029-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2007-02-06 US disclosed
US-7173029-B2 Fused heteroaryl derivatives ASTELLAS PHARMA INC. (JP) 2007-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137584-A1 FUSED HETEROARYL DERIVATIVES PIK3CD, PIK3R3, PIK3C2A PRKCI 266/4885VCP 2208/4885MEN1 3330/4885
US-20070037805-A1 Fused heteroaryl derivatives PIK3CD, PIK3R3, PIK3C2A PRKCI 266/4885VCP 2208/4885MEN1 3330/4885
US-20100137585-A1 FUSED HETEROARYL DERIVATIVES PIK3CD, PIK3R3, PIK3C2A PRKCI 266/4885VCP 2208/4885MEN1 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.